Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ethos Technologies Inc. - Class A Common Stock (NQ:LIFE)

10.20 -0.60 (-5.56%)
Streaming Delayed Price Updated: 1:09 PM EDT, Mar 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ethos Technologies Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Beat of Life Entertainment's 'Diya Jalao Roshni Lao' Campaign: Lighting Up Lives and Preserving Tradition!
The "Diya Jalao Roshni Lao" campaign was initiated by the Beat of Life Entertainment company in 2022. Its aim is to draw people's attention to our culture, the hard work of potters, hope, their lives,... 
Via IssueWire
Topics Religion
News headline image
aTyr Pharma to Present at November Investor Conferences
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD
Multiple centers in the U.S. are open for enrollment 
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
Analyst Expectations for aTyr Pharma's Future ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for aTyr Pharma ↗
 
Via Benzinga
News headline image
aTyr Pharma: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Where aTyr Pharma Stands With Analysts ↗
 
Via Benzinga
News headline image
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
$12M Bet On This Trucking Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗
The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks... 
Via Benzinga
News headline image
aTyr Pharma's Cash Runway Secured till 2026, Despite Lack of Material Catalysts: Oppenheimer Analyst ↗
Oppenheimer has downgraded aTyr Pharma Inc (NASDAQ: LIFE) to Perform from Outperform, citing a few material catalysts in the next few quarters. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2023 ↗
 
Via Benzinga
News headline image
aTyr Pharma's Earnings: A Preview ↗
 
Via Benzinga
News headline image
aTyr Pharma: Q2 Earnings Insights ↗
  aTyr Pharma (NASDAQ:LIFE) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
7 Growth Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2023 ↗
Bard AI has consistently outperformed, and it has identified seven growth stocks that it believes will deliver triple-digit returns. 
Via InvestorPlace
News headline image
3 Stocks and Cryptos With the Highest Potential Returns ↗
If you're only worried about upside, these stocks and cryptos have some of the highest possible returns in the market. 
Via InvestorPlace
News headline image
7 Hot Growth Stocks Poised to Triple in 2023 ↗
These hot growth stocks to buy can triple in price in 2023, with some holding impressive upside that's much higher. 
Via InvestorPlace
News headline image
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank ↗
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
This Company Is Beginning A Pivotal Phase 3 EFZO-FIT™ Study. Could It Be A Much-Needed Treatment For Pulmonary Sarcoidosis? ↗
Most people may never have heard of sarcoidosis, an inflammatory disease that affects about 1.2 million people worldwide.  
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 64 companies achieved new lows for the year. 
Via Benzinga
News headline image
Beat Of Life Entertainment- A One Stop Solution For Internet Marketing
Internet marketing is the solution for business development in the digitalization era. 
Via IssueWire
News headline image
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary ↗
 
Via Benzinga
News headline image
aTyr Pharma Gets FDA Fast Track Status For Systemic Sclerosis Candidate ↗
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for aTyr Pharma’s (NASDAQ: LIFE) lead therapeutic candidate, efzofitimod, for the treatment of systemic sclerosis... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
  
Via Benzinga
News headline image
NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks ↗
Raymond James cut the price target for NexImmune, Inc. (NASDAQ: NEXI) from $12 to $3. NexImmune shares rose 2.4% to $1.29 in pre-market trading. 
Via Benzinga
News headline image
A Preview Of aTyr Pharma's Earnings ↗
  aTyr Pharma (NASDAQ:LIFE) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. Analysts estimate that aTyr Pharma... 
Via Benzinga
News headline image
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 15, 2022 ↗
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.